Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Share this content:
Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate
Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

TUESDAY, Sept. 19, 2017 (HealthDay News) -- For obese women undergoing cesarean delivery, a postoperative 48-hour course of cephalexin and metronidazole reduces the rate of surgical site infection (SSI) within 30 days compared with placebo, according to a study published in the Sept. 19 issue of the Journal of the American Medical Association.

Amy M. Valent, D.O., from the Oregon Health & Science University in Portland, and colleagues compared oral cephalexin and metronidazole versus placebo for 48 hours following cesarean delivery for the prevention of SSI in obese women who had received standard intravenous preoperative cephalosporin prophylaxis. Two hundred two women were randomized to cephalexin and metronidazole and 201 to placebo every eight hours for 48 hours. The primary outcome was SSI within 30 days after cesarean delivery, defined as any superficial incisional, deep incisional, or organ/space infections.

A total of 382 women completed the trial. The researchers found that the overall rate of SSI was 10.9 percent in the cohort. Overall, 6.4 and 15.4 percent of women in the cephalexin-metronidazole and placebo groups, respectively, were diagnosed with SSI (relative risk, 0.41). No serious adverse events, including allergic reaction, were reported in either group.

"For prevention of SSI among obese women after cesarean delivery, prophylactic oral cephalexin and metronidazole may be warranted," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

High Costs Associated With Physician Burnout, Attrition

High Costs Associated With Physician Burnout, Attrition

Economic loss at Stanford over two years expected to range from $15.5 million to $55.5 million

Insulin Doesn't Prevent Diabetes in Relatives of T1DM Patients

Insulin Doesn't Prevent Diabetes in Relatives of T1DM ...

Oral insulin doesn't delay onset in autoantibody-positive relatives of patients with type 1 diabetes

Workplace Sexual Harassment Ongoing in Women, Up for Men

Workplace Sexual Harassment Ongoing in Women, Up for ...

Women report more adverse effects after SH than men, but SH can trigger depression, anxiety in men

is free, fast, and customized just for you!

Already a member?

Sign In Now »